AbbVie, a global leader in biopharmaceutical innovation, is seeking 顶尖 scientists to join its prestigious Postdoctoral Program, a cornerstone of the company’s commitment to advancing breakthrough therapies for patients. The program offers early-career researchers a unique opportunity to collaborate with industry-leading scientists on cutting-edge projects spanning discovery, development sciences, and aesthetics, with a particular focus on oncology. Postdoctoral fellows serve as technical innovators, tasked with developing and optimizing new laboratory methods, analyzing complex data, and publishing findings in high-impact journals.
“The Postdoctoral Program is vital to fostering the next generation of scientific leaders,” said a senior AbbVie researcher. “Participants gain hands-on experience in drug development, working across disciplines to solve unmet medical needs.”
Oncology Focus: In Vivo Pharmacology and Tumor Penetration Research
A key highlight of the program is a newly announced position in the In Vivo Pharmacology group within Oncology Discovery Research, based at AbbVie’s Bay Area site in South San Francisco. The role targets scientists with expertise in in vivo biodistribution imaging, particularly for studying antibody penetration in heterogeneous tumor models. Fellows will collaborate with cross-functional teams—including quantitative translational ADME sciences, biology, and pathology—to develop mathematical models describing how antibodies interact with complex tumors.
The Bay Area site’s state-of-the-art facilities, including a cutting-edge vivarium equipped with bioluminescence, fluorescent, ultrasound, and photoacoustic imaging technologies, provide an ideal environment for this work. Fellows will also have access to wet-lab resources for supporting in vitro experiments and the opportunity to collaborate across AbbVie’s global sites in Lake County and Worcester. The project aims to improve antibody-based therapies such as bispecifics and antibody-drug conjugates, with the ultimate goal of enhancing tumor uptake and patient outcomes.
Career Development and Collaborative Culture
The 2-3 year program is designed to bridge academic research with industrial innovation, offering fellows mentorship from AbbVie’s scientific leadership and exposure to the full drug development lifecycle. Successful applicants from U.S. academic institutions will contribute to AbbVie’s pipeline while building skills in teamwork, data communication, and regulatory compliance. Key responsibilities include designing novel tumor models, analyzing imaging data, publishing results in peer-reviewed journals, and collaborating with experts to translate findings into clinical applications.
“AbbVie’s postdocs are not just researchers—they’re problem-solvers,” noted the hiring team. “They join a culture of collaboration where ideas are shared across labs and functions, accelerating the pace of discovery.”
With a focus on scientific rigor, safety, and cross-disciplinary innovation, AbbVie’s Postdoctoral Program offers a transformative path for scientists eager to make an impact in global healthcare. Applications are now open for candidates ready to push the boundaries of biopharmaceutical research and contribute to therapies that could redefine patient care.
- Ariana Madix Reveals The Beauty Treatments She’s Had
- Bettina Anderson’s Surgery Rumors Spotlight Kimberly Guilfoyle
- Stassie Karanikolaou Regrets Feeling Pressured Into BBL Surgery
